Cargando…

The Gut Microbiota-Bile Acids-TGR5 Axis Mediates Eucommia ulmoides Leaf Extract Alleviation of Injury to Colonic Epithelium Integrity

Eucommia ulmoides leaves (EL) are rich in phenolic acids and flavonoids, showing enhancing intestinal health effects. The intestinal microbiota-bile acid axis plays important roles in the occurrence and recovery of inflammatory bowel disease (IBD). However, whether EL extract (ELE) has regulatory ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Zhenya, Niu, Kai-Min, Liu, Yichun, Lin, Chong, Wu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416499/
https://www.ncbi.nlm.nih.gov/pubmed/34489916
http://dx.doi.org/10.3389/fmicb.2021.727681
_version_ 1783748196525146112
author Zhai, Zhenya
Niu, Kai-Min
Liu, Yichun
Lin, Chong
Wu, Xin
author_facet Zhai, Zhenya
Niu, Kai-Min
Liu, Yichun
Lin, Chong
Wu, Xin
author_sort Zhai, Zhenya
collection PubMed
description Eucommia ulmoides leaves (EL) are rich in phenolic acids and flavonoids, showing enhancing intestinal health effects. The intestinal microbiota-bile acid axis plays important roles in the occurrence and recovery of inflammatory bowel disease (IBD). However, whether EL extract (ELE) has regulatory effects on the intestinal microbiota, bile acid metabolism, and IBD is still unclear. To fill this gap, 2% dextran sulfate sodium (DSS)-induced mild IBD in a C57BL/6J mouse model that was treated with 200 or 400 mg/kg (intake dose/body weight) ELE was used. Oral ELE supplementation alleviated DSS-induced shortening of colon and colonic epithelial injury. Compared with the DSS group, ELE supplementation significantly decreased Toll-like receptor 4 (TLR4) and interlukin-6 (IL-6) and increased occludin and claudin-1 mRNA expression level in the colon (p < 0.05). Combined 16S rRNA gene sequencing and targeted metabolomic analyses demonstrated that ELE significantly improved the diversity and richness of the intestinal microbiota, decreased the abundance of Bacteroidaceae, and increased Akkermansiaceae and Ruminococcaceae abundance (p < 0.05) compared with DSS-induced IBD mice. Moreover, ELE significantly increased the serum contents of deoxycholic acid (DCA) and tauroursodeoxycholic acid (TUDCA), which were highly positively correlated with Akkermansia and unidentified_Ruminococccaceae relative to the DSS group. We then found that ELE increased Takeda G-protein coupled receptor 5 (TGR5), claudin-1, and occludin mRNA expression levels in the colon. In the Caco-2 cell model, we confirmed that activation of TGR5 improved the reduction in transepithelial electoral resistance (TEER) and decreased the permeability of FITC-dextran on monolayer cells induced by LPS (p < 0.05). siRNA interference assays showed that the decrease in TGR5 expression led to the decrease in TEER, an increase in FITC-dextran permeability, and a decrease in claudin-1 protein expression in Caco-2 cells. In summary, ELE alleviated IBD by influencing the intestinal microbiota structure and composition of bile acids, which in turn activated the colonic TGR5 gene expression in the colon and promoted the expression of tight junction proteins. These findings provide new insight for using ELE as a functional food with adjuvant therapeutic effects in IBD.
format Online
Article
Text
id pubmed-8416499
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84164992021-09-05 The Gut Microbiota-Bile Acids-TGR5 Axis Mediates Eucommia ulmoides Leaf Extract Alleviation of Injury to Colonic Epithelium Integrity Zhai, Zhenya Niu, Kai-Min Liu, Yichun Lin, Chong Wu, Xin Front Microbiol Microbiology Eucommia ulmoides leaves (EL) are rich in phenolic acids and flavonoids, showing enhancing intestinal health effects. The intestinal microbiota-bile acid axis plays important roles in the occurrence and recovery of inflammatory bowel disease (IBD). However, whether EL extract (ELE) has regulatory effects on the intestinal microbiota, bile acid metabolism, and IBD is still unclear. To fill this gap, 2% dextran sulfate sodium (DSS)-induced mild IBD in a C57BL/6J mouse model that was treated with 200 or 400 mg/kg (intake dose/body weight) ELE was used. Oral ELE supplementation alleviated DSS-induced shortening of colon and colonic epithelial injury. Compared with the DSS group, ELE supplementation significantly decreased Toll-like receptor 4 (TLR4) and interlukin-6 (IL-6) and increased occludin and claudin-1 mRNA expression level in the colon (p < 0.05). Combined 16S rRNA gene sequencing and targeted metabolomic analyses demonstrated that ELE significantly improved the diversity and richness of the intestinal microbiota, decreased the abundance of Bacteroidaceae, and increased Akkermansiaceae and Ruminococcaceae abundance (p < 0.05) compared with DSS-induced IBD mice. Moreover, ELE significantly increased the serum contents of deoxycholic acid (DCA) and tauroursodeoxycholic acid (TUDCA), which were highly positively correlated with Akkermansia and unidentified_Ruminococccaceae relative to the DSS group. We then found that ELE increased Takeda G-protein coupled receptor 5 (TGR5), claudin-1, and occludin mRNA expression levels in the colon. In the Caco-2 cell model, we confirmed that activation of TGR5 improved the reduction in transepithelial electoral resistance (TEER) and decreased the permeability of FITC-dextran on monolayer cells induced by LPS (p < 0.05). siRNA interference assays showed that the decrease in TGR5 expression led to the decrease in TEER, an increase in FITC-dextran permeability, and a decrease in claudin-1 protein expression in Caco-2 cells. In summary, ELE alleviated IBD by influencing the intestinal microbiota structure and composition of bile acids, which in turn activated the colonic TGR5 gene expression in the colon and promoted the expression of tight junction proteins. These findings provide new insight for using ELE as a functional food with adjuvant therapeutic effects in IBD. Frontiers Media S.A. 2021-08-18 /pmc/articles/PMC8416499/ /pubmed/34489916 http://dx.doi.org/10.3389/fmicb.2021.727681 Text en Copyright © 2021 Zhai, Niu, Liu, Lin and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Zhai, Zhenya
Niu, Kai-Min
Liu, Yichun
Lin, Chong
Wu, Xin
The Gut Microbiota-Bile Acids-TGR5 Axis Mediates Eucommia ulmoides Leaf Extract Alleviation of Injury to Colonic Epithelium Integrity
title The Gut Microbiota-Bile Acids-TGR5 Axis Mediates Eucommia ulmoides Leaf Extract Alleviation of Injury to Colonic Epithelium Integrity
title_full The Gut Microbiota-Bile Acids-TGR5 Axis Mediates Eucommia ulmoides Leaf Extract Alleviation of Injury to Colonic Epithelium Integrity
title_fullStr The Gut Microbiota-Bile Acids-TGR5 Axis Mediates Eucommia ulmoides Leaf Extract Alleviation of Injury to Colonic Epithelium Integrity
title_full_unstemmed The Gut Microbiota-Bile Acids-TGR5 Axis Mediates Eucommia ulmoides Leaf Extract Alleviation of Injury to Colonic Epithelium Integrity
title_short The Gut Microbiota-Bile Acids-TGR5 Axis Mediates Eucommia ulmoides Leaf Extract Alleviation of Injury to Colonic Epithelium Integrity
title_sort gut microbiota-bile acids-tgr5 axis mediates eucommia ulmoides leaf extract alleviation of injury to colonic epithelium integrity
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416499/
https://www.ncbi.nlm.nih.gov/pubmed/34489916
http://dx.doi.org/10.3389/fmicb.2021.727681
work_keys_str_mv AT zhaizhenya thegutmicrobiotabileacidstgr5axismediateseucommiaulmoidesleafextractalleviationofinjurytocolonicepitheliumintegrity
AT niukaimin thegutmicrobiotabileacidstgr5axismediateseucommiaulmoidesleafextractalleviationofinjurytocolonicepitheliumintegrity
AT liuyichun thegutmicrobiotabileacidstgr5axismediateseucommiaulmoidesleafextractalleviationofinjurytocolonicepitheliumintegrity
AT linchong thegutmicrobiotabileacidstgr5axismediateseucommiaulmoidesleafextractalleviationofinjurytocolonicepitheliumintegrity
AT wuxin thegutmicrobiotabileacidstgr5axismediateseucommiaulmoidesleafextractalleviationofinjurytocolonicepitheliumintegrity
AT zhaizhenya gutmicrobiotabileacidstgr5axismediateseucommiaulmoidesleafextractalleviationofinjurytocolonicepitheliumintegrity
AT niukaimin gutmicrobiotabileacidstgr5axismediateseucommiaulmoidesleafextractalleviationofinjurytocolonicepitheliumintegrity
AT liuyichun gutmicrobiotabileacidstgr5axismediateseucommiaulmoidesleafextractalleviationofinjurytocolonicepitheliumintegrity
AT linchong gutmicrobiotabileacidstgr5axismediateseucommiaulmoidesleafextractalleviationofinjurytocolonicepitheliumintegrity
AT wuxin gutmicrobiotabileacidstgr5axismediateseucommiaulmoidesleafextractalleviationofinjurytocolonicepitheliumintegrity